Semaglutide — the active pharmaceutical ingredient in both Ozempic and Wegovy — became a major search term as consumers sought to understand the molecule, compare branded versions, and find compounded alternatives during shortage periods. Research on semaglutide's mechanisms and emerging indications drives ongoing search interest.
Semaglutide currently drives about 890K/mo in monthly search volume, +545% year over year. Common use cases include Pharmaceutical content, Medical education, Compounding pharmacy marketing.
Related keywords people also research: Ozempic, Wegovy, GLP 1 Medications, tirzepatide, Berberine, GLP 1 Diet Protocol.
Explore more Healthcare Trends.
More healthcare trends: GLP-1 Medications, Ozempic, Wegovy, Concierge Medicine, Preventive Bloodwork, Functional Medicine, Telehealth, Longevity Medicine, Biomarker Testing, Wearable Health Monitoring, Postpartum Care, Pelvic Floor Therapy.
Tagged: Semaglutide, GLP-1, Active ingredient.